Neuroethics and neural-data governance enter mainstream policy debate

UNESCO's move toward a global neurotechnology ethics instrument, alongside concerns over consumer EEG, cognitive enhancement, and neural-data commercialization, signals growing pressure for rules on consent, privacy, ownership, equity, and autonomy. Expert work on psychiatric biomarkers reinforces that practical safeguards require shared data, replication, prospective validation, and regulator engagement; formal adoption and implementation matter more than draft principles alone.